Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis
Clinical trial NCT04093895 · COMPLETED
Trial details
- NCT number
- NCT04093895
- Sponsor
- Geistlich Pharma AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2020-06-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.